comparemela.com

Latest Breaking News On - Singapore december - Page 4 : comparemela.com

Merus Announces Publication of Abstracts on MCLA-129 for Presentation at ESMO Asia Congress 2023

-  Oral presentation on MCLA-129 in combination with osimertinib as first line therapy, and in previously treated, NSCLC on Sunday, December 3 at .

Cambridge
Cambridgeshire
United-kingdom
Netherlands
Zenocutuzumab-zeno
Company-conference-call
Early-access-program
European-society-for-medical-oncology
Development-strategy
Exchange-commission
Sasia-congress
European-society

Wolbachia-Infected Aedes Aegypti Mosquitoes to be Unleased in Singapore to Quash Dengue Threat

Singapore expands its Wolbachia program, releasing male mosquitoes to combat dengue. Strategic zones targeted for population suppression show promising results.

Telok-blangah
Singapore-general
Singapore
Netherlands
Marine-parade
Bukit-merah
Holland
John-lopez
International-vector
National-environment-agency
National-environmental-agency
Tech-times

Merus Announces Financial Results for the Third Quarter 2023 and Provides Business Update

Merus Announces Financial Results for the Third Quarter 2023 and Provides Business Update
finanzen.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.ch Daily Mail and Mail on Sunday newspapers.

China
Netherlands
Cambridge
Cambridgeshire
United-kingdom
Meru-biclonics
Eli-lilly
Zenocutuzumab-zeno
Twitter
Sasia-congress
European-society-for-medical-oncology
Incyte-corporation

Merus N.V.: Merus Announces Financial Results for the Third Quarter 2023 and Provides Business Update

Merus N.V.: Merus Announces Financial Results for the Third Quarter 2023 and Provides Business Update
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

China
Netherlands
Cambridge
Cambridgeshire
United-kingdom
Zenocutuzumab-zeno
Eli-lilly
Meru-biclonics
Twitterand-linkedin
Betta-pharmaceuticals-co
Incyte-corporation
Nasdaq

Merus Announces Business Update Conference Call

Zeno interim clinical data continues to show robust efficacy in NRG1+ NSCLC and PDAC: Sufficient clinical data expected in 1H24 to support potential BLA.

Cambridge
Cambridgeshire
United-kingdom
United-states
Netherlands
Madrid
Spain
American
Andrew-joe
Zenocutuzumab-zeno
Alison-schram
Early-access-program

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.